William Blair & Company’s Precision BioSciences DTIL Stock Holding History

William Blair & Company’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-911	Closed	-$315K	–	1981
2021 Q3	$315K	Sell	911 -3	-0.3%	-$1.02K	﹤0.01%	1329
2021 Q2	$343K	Buy	914 +79	+9%	+$23.7K	﹤0.01%	1298
2021 Q1	$259K	Buy	835 +110	+15%	+$38.5K	﹤0.01%	1390
2020 Q4	$181K	Buy	+725	New	+$178K	﹤0.01%	1465
2020 Q3	–	Sell	-1,190	Closed	-$297K	–	1730
2020 Q2	$297K	Buy	+1,190	New	+$261K	﹤0.01%	1096

Other funds holding DTIL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

William Blair & Company's DTIL Position: Q4 2021 in Review

William Blair & Company sold out of Precision BioSciences (DTIL) in Q4 2021, closing a stake of 911 shares — an estimated $315K sold.

William Blair & Company first reported a position in DTIL in Q2 2020 and held it in 5 quarters. The position peaked at $343K in Q2 2021. 134 funds tracked by Wall St. Rank hold DTIL as of Q4 2021.

William Blair & Company reported no remaining Precision BioSciences position as of Q4 2021 after selling out during the quarter.
William Blair & Company sold 911 Precision BioSciences shares in Q4 2021, an estimated $315K.
William Blair & Company first reported a position in Precision BioSciences in Q2 2020 and held it in 5 quarters.
William Blair & Company's Precision BioSciences position peaked at $343K in Q2 2021.
134 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2021.

Based on William Blair & Company's 13F filing for Q4 2021, filed 14 Feb 2022.